Hemangiomas of infancy: Treatment of ulceration in the head and neck

Archives of Facial Plastic Surgery

Volumn 7, Issue 5, 2005, Pages 312-315

  Thomas, Roy F ^a   Hornung, Robin L ^b,c   Manning, Scott C ^b,c   Perkins, Jonathan A ^b,c  

^a MADIGAN ARMY MEDICAL CENTER   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; CORTICOSTEROID;

ARTICLE; EPIDEMIOLOGY; FACE TUMOR; FOLLOW UP; HEAD AND NECK TUMOR; HEMANGIOMA; HUMAN; INFANT; LOW LEVEL LASER THERAPY; METHODOLOGY; MULTIMODALITY CANCER THERAPY; NEWBORN; PHYSIOLOGY; RISK ASSESSMENT; SKIN ULCER; TREATMENT OUTCOME; WOUND HEALING;

ADRENAL CORTEX HORMONES; COMBINED MODALITY THERAPY; FACIAL NEOPLASMS; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HEMANGIOMA; HUMANS; INFANT; INFANT, NEWBORN; INTERFERON ALFA-2A; LASER THERAPY, LOW-LEVEL; RISK ASSESSMENT; SAMPLING STUDIES; SKIN ULCER; TREATMENT OUTCOME; WOUND HEALING;

EID: 33644682808     PISSN: 15212491     EISSN: 15383660     Source Type: Journal    
DOI: 10.1001/archfaci.7.5.312     Document Type: Review

References (16)

1. Bruckner AL, Frieden IJ. Hemangiomas of infancy. J Am Acad Dermatol. 2003;48:477-493.
2. Achauer BM, Chang CJ, Vander Kam VM. Management of hemangioma of infancy: review of 245 patients. Plast Reconstr Surg. 1997;99:1301-1308.
3. Kim HJ, Colombo M, Freiden IJ. Ulcerated hemangiomas: clinical characteristics and response to therapy. J Am Acad Dermatol. 2001;44:962-972.
4. Waner M, Suen JY. The natural history of hemangiomas. In: Waner M, Suen JY, ed. Hemangiomas and Vascular Malformations of the Head and Neck. New York, NY: Wiley-Liss; 1999:13-45.
5. Liang MG, Frieden IJ. Perineal and lip ulceration as the presenting manifestation of hemangioma of infancy. Pediatrics. 1997;99:256-259.
6. Waner M, North PE, Scherer KA, et al. The nonrandom distribution of facial hemangiomas. Arch Dermatol. 2003;139:869-875.
7. David LR, Malek MM, Argenta LC. Efficacy of pulse dye laser therapy for the treatment of ulcerated haemangiomas: a review of 78 patients. Br J Plast Surg. 2003; 56:317-327.
8. Esterly NB. Cutaneous hemangiomas, vascular stains and malformations, and associated syndromes. Curr Probl Pediatr. 1996;26:3-39.
9. Weiss AH. Adrenal suppression after corticosteroid injection of periocular hemangiomas. Am J Ophthalmol. 1989;107:518-522.
10. Morelli JG, Tan OT, Weston WL. Treatment of ulcerated hemangiomas with the pulsed tunable dye laser. AJDC. 1991;145:1062-1064.
11. Ezekowitz RA, Mulliken JB, Folkman J. Interferon alfa-2a for life-threatening hemangiomas of infancy. N Engl J Med. 1992;326:1456-1463.
12. Enjolras O, Breviere GM, Roger G, et al. Vincristine therapy for function- and life-threatening hemangioma of infancy. Arch Pediatr Adolesc Med. 2004;11:99-107.
13. Sugarman JL, Mauro TM, Frieden IJ, et al. Treatment of an ulcerated hemangioma with recombinant platelet-derived growth factor. Arch Dermatol. 2002; 138:314-316.
14. Metz BJ, Rubenstein MC, Levy ML, et al. Response of ulcerated perineal hemangiomas of infancy to becaplermin gel, a recombinant human platelet-derived growth factor. Arch Dermatol. 2004;140:867-870.
15. Dahl MV. Imiquimod: an immune response modifier. J Am Acad Dermatol. 2000; 43:S1-S5.
16. Welsh O, Olazaran Z, Gomez M, et al. Treatment of infantile hemangiomas with short-term application of imiquimod 5% cream. J Am Acad Dermatol. 2004;51:639-642.